StockAnalyzer

Financial Analysis

DashboardSectorsComparablesScreenerUniverseMicrocapsAI 2nd OrderTheme MapEnergy & MaterialsMacroWatchlistCompareMi CarteraPortfolio

Recent

v0.1
PVA.MC$0.25+0.00%
Fair $0.25+0.0%

PVA.MC

Pescanova, S.A.

Consumer Defensive / Farm ProductsMCE

$0.25

+0.00 (+0.00%)

Fairly Valued+0.0%Fair Value $0.25Fund rank 27/100 · Data gapFallback financials|
SA 26/D
F-Score: 4/9
Low Profitability

FCF base 3Y

n/d

n/d CAGR · yield n/d

FCF base 5Y

n/d

n/d base · n/d expected

Precio de entrada

n/d

MOS 34% · confianza 19%

FCF escenarios

weak_data · normalized FCF $-98000.00 · quality 49.3/100

Data gap 27/100
Bear 5Yn/dn/d
Base 5Yn/dn/d
Bull 5Yn/dn/d
Return 0/100Downside 20/100Model quality 13/100Data QA 20/100

Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.

Quality + valuation scorecard

SA Score

26/100

D

Piotroski

4/9

balance/quality

Valuation

50/100

+0.0% upside

5Y CAGR

+0.0%

50/100

Data QA

16/100

SEC 0%

Latest source: unknownPeriods: 4Warnings: 1unknown: 4
No SEC-backed annual rows; valuation uses fallback financial data. Insufficient audited annual history (<3 SEC-backed years); composite fair value and forward targets are disabled until manually verified. ROE is 1.5%, below the 5% threshold
Thesis & Journal · PVA.MCLocal privado en este navegador · Pescanova, S.A.
Plantilla tipo buy-side: tesis, bull/base/bear, catalizadores, riesgos, kill criteria y fecha de revisión. Esto no gasta GPT-5.5; luego lo usamos como contexto del memo.

Sin guardar todavía.

Market Cap

$7M

P/E

N/A

•

EV/EBITDA

22.0x

↑

ROE

1.5%

↓

Gross Margin

N/A

•

Debt/Equity

-1.47

↓
52-Week Range$0
$0$0

TradingView lightweight chart

PVA.MC price, volumen y niveles de valoración

Último $0.246Periodo -96.3%
Fair value: $0.246

Price & Ratios

Absolute Values (Left Axis)

Ratios / Percentages (Right Axis)

Financial statement dashboard

Crecimiento, márgenes y provenance

2022–2025 · 3 años de histórico normalizado

Revenue CAGR

+4.1%

FCF CAGR

—

FCF margin

-30.9%

FCF / Net income

1.00x

Latest source

Provider fallback

Margin decomposition

Último año: revenue $317000.0 · net income $-98000.0 · FCF $-98000.0

2022-FY → 2025-FY

Gross margin

—— pts

Operating margin

12.9%+1640.3% pts

Net margin

-30.9%+2414.6% pts

FCF margin

-30.9%+20.0% pts
MetricTTM
2025
2024
2023
2022
Income Statement
Revenue$317000.00$317000.00$309000.00$300000.00$281000.00
Net Income$-98000.00$-98000.00$-670000.00$-686000.00$-6.9M
EBITDA$740000.00$740000.00$4.1M$3.8M$-1.8M
EPS-0.00-0.00-0.02-0.02-0.24
Operating Margin12.9%12.9%11.7%15.7%-1627.4%
Net Margin-30.9%-30.9%-216.8%-228.7%-2445.6%
Balance Sheet
Debt/Equity-1.47-1.47-0.33-0.37-0.42
Current Ratio1.031.03———
Cash Flow
Free Cash Flow$-98000.00$-98000.00$-670000.00$106000.00$-143000.00
Returns
ROE1.5%1.5%10.5%12.0%136.9%
Valuation
EV/EBITDA22.0422.042.912.39—
Growth & Yield
Revenue Growth2.6%2.6%3.0%6.8%—
EPS Growth85.4%85.4%2.3%90.0%—

Revenue, Net Income & Free Cash Flow ($B)

Margins (%)

Returns (%)

Leverage & Liquidity

Reverse DCF · market-implied EPS growthterminal P/E 15.0x · COE 10.0%
Reverse DCF requires positive EPS; loss-making or zero-EPS companies cannot produce a clean EPS hurdle.

Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.

Return attribution · 1Y approxreconcilia total -25.7%

Total return

-25.7%

Start / end P/E

n/dx → n/dx

EPS bridge

-0.02 → -0.00

Residual

-25.7%

EPS growthn/d
Multiple reratingn/d
Dividend+0.0%
Residual / FX / buybacks / cross-term-25.7%

EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.

Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.